Our product lines include clinical chemistry reagents, point-of-care tests, blood collection tube raw materials as well as enzymes and specialty biochemicals.
Headquartered in Burlington, MA, for 40 years SEKISUI Diagnostics has been committed to helping improve the lives of patients by providing innovative medical diagnostics to physicians and laboratories. We continue to invest in the areas of diabetes, infectious disease, coagulation, diagnostic enzymes and automated systems, and have a leading position as a provider of rapid tests in the US and high throughput coagulation systems in Japan. Our workforce spans six sites located in four countries. We are a sister company to SEKISUI Medical in Japan, making us a worldwide company with R&D and Manufacturing facilities on three continents. We develop, manufacture, and supply billions of tests each year to the global healthcare market through our commercial networks and partners. Our product lines include:
• Clinical chemistry reagents
• Coagulation reagents
• Point-of-care rapid tests and immunoassay system
• Enzymes and specialty biochemicals
10/14/2025
At SEKISUI Diagnostics, our culture is powered by people who bring passion, creativity, and integrity to everything they do.
As one team, we’re united by shared values—innovation, quality, and collaboration—that drive us to make a lasting impact in diagnostics and beyond.
Join us at the American Academy of Family Physicians at booth 1606 to discover our newest point-of-care offerings!
10/07/2025
Behind every supply chain decision is a patient waiting for answers. That’s why SEKISUI Diagnostics is committed to making ours global, responsive, and dependable. https://bit.ly/41obfbg
10/01/2025
This Breast Cancer Awareness Month, SEKISUI Diagnostics stands with the global community in raising awareness and supporting early detection. Together, let’s promote education, empower action, and make a difference in the fight against breast cancer.
09/30/2025
In healthcare, patient experience isn't just "nice to have"— it’s integral. Poor wait times, multiple swab samples, and delayed results can hurt how patients rate their care and, ultimately, how providers get paid.
But what if there’s a better way? This week, we're revisiting our DX Dialogue article that delved into the patient satisfaction benefits for providers who choose combo testing for common respiratory illnesses like Flu and COVID.
Thanks to everyone who stopped by the SEKISUI Diagnostics booth at ! We loved connecting with you and sharing how our latest point-of-care diagnostic solutions can support better care for your pediatric patients. See you at the next !
09/29/2025
This World Heart Day, SEKISUI Diagnostics emphasizes the vital role of diagnostics in cardiovascular health. Early detection and monitoring through clinical testing can help prevent heart disease and improve patient outcomes. Together, let’s raise awareness and promote heart-healthy lives worldwide.
09/25/2025
Featured in Repertoire Magazine!
We’re excited to share that our Account Executive, Bill West, contributed an article in the September 2025 issue of Repertoire (page 31).
In it, Bill highlights how distributor reps help physician practices successfully navigate respiratory season, ensuring providers have the tests, vaccines, and supplies they need when demand is at its peak.
We’re grateful to have Bill’s expertise supporting the providers and patients we serve.
At SEKISUI Diagnostics, our solutions are designed to support clinicians across diverse care settings by delivering accurate, reliable results at the point of care.
This video highlights the breadth of where our products are used and how they help close the gap between testing and treatment.
Better health outcomes start with the right diagnosis at the right time. At SEKISUI Diagnostics, we believe everyone deserves that foundation for care. https://bit.ly/3UP7kAA
09/19/2025
From flu season to STI screening, point-of-care testing can help student health centers deliver faster, more complete care. Our latest DX Dialogue article can help you set up your program the right way.
Better diagnostics mean better outcomes. Our team takes pride in supporting customers and partners worldwide with tools that make a difference in patient health every day. https://bit.ly/4fX4L9f
Be the first to know and let us send you an email when SEKISUI Diagnostics posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Headquartered in Burlington, MA, for over 35 years Sekisui Diagnostics has been committed to helping improve the lives of patients by providing innovative medical diagnostics to physicians and laboratories. We have a history of innovation which includes, the first homogeneous test for LDL and the first plastic vacuum blood collection tube. We continue to invest in the areas of diabetes, infectious disease, coagulation, diagnostic enzymes and automated systems, and have a leading position as a provider of rapid tests in the US and high throughput coagulation systems in Japan.
Our workforce includes ~450 employees, in six sites located in four countries. We are a sister company to Sekisui Medical in Japan and in China, making us a worldwide company with R&D and Manufacturing facilities on three continents.
We develop, manufacture, and supply billions of tests each year to the global healthcare market through our commercial networks and partners. Our product lines include:
· Clinical chemistry systems and reagents
· Coagulation systems and reagents
· Point-of-care molecular, rapid tests and immunoassay system